Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.

COIITSS Study Investigators, Annane D, Cariou A, Maxime V, Azoulay E, D'honneur G, Timsit JF, Cohen Y, Wolf M, Fartoukh M, Adrie C, Santré C, Bollaert PE, Mathonet A, Amathieu R, Tabah A, Clec'h C, Mayaux J, Lejeune J, Chevret S.

JAMA. 2010 Jan 27;303(4):341-8. doi: 10.1001/jama.2010.2. Erratum in: JAMA. 2010 May 5;303(17):1698.

PMID:
20103758
2.

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E.

JAMA. 2002 Aug 21;288(7):862-71. Erratum in: JAMA. 2008 Oct 8;300(14):1652. Chaumet-Riffaut, Philippe [corrected to Chaumet-Riffaud, Philippe].

PMID:
12186604
3.

Should glucocorticoid-induced hyperglycemia be treated in patients with septic shock?

Van den Berghe G.

JAMA. 2010 Jan 27;303(4):365-6. doi: 10.1001/jama.2010.41. No abstract available.

PMID:
20103763
4.

The current management of septic shock.

Russel JA.

Minerva Med. 2008 Oct;99(5):431-58. Review.

PMID:
18971911
5.

Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.

Keh D, Trips E, Marx G, Wirtz SP, Abduljawwad E, Bercker S, Bogatsch H, Briegel J, Engel C, Gerlach H, Goldmann A, Kuhn SO, Hüter L, Meier-Hellmann A, Nierhaus A, Kluge S, Lehmke J, Loeffler M, Oppert M, Resener K, Schädler D, Schuerholz T, Simon P, Weiler N, Weyland A, Reinhart K, Brunkhorst FM; SepNet–Critical Care Trials Group.

JAMA. 2016 Nov 1;316(17):1775-1785. doi: 10.1001/jama.2016.14799.

PMID:
27695824
6.

Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.

Annane D, Timsit JF, Megarbane B, Martin C, Misset B, Mourvillier B, Siami S, Chagnon JL, Constantin JM, Petitpas F, Souweine B, Amathieu R, Forceville X, Charpentier C, Tesnière A, Chastre J, Bohe J, Colin G, Cariou A, Renault A, Brun-Buisson C, Bellissant E; APROCCHSS Trial Investigators.

Am J Respir Crit Care Med. 2013 May 15;187(10):1091-7. doi: 10.1164/rccm.201211-2020OC.

PMID:
23525934
7.
8.

Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome.

Annane D, Sébille V, Bellissant E; Ger-Inf-05 Study Group.

Crit Care Med. 2006 Jan;34(1):22-30.

PMID:
16374152
9.

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K.

Crit Care Med. 1999 Apr;27(4):723-32.

PMID:
10321661
10.

Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study.

Moreno R, Sprung CL, Annane D, Chevret S, Briegel J, Keh D, Singer M, Weiss YG, Payen D, Cuthbertson BH, Vincent JL.

Intensive Care Med. 2011 Nov;37(11):1765-72. doi: 10.1007/s00134-011-2334-x. Epub 2011 Aug 17.

PMID:
21847649
11.

Hydrocortisone therapy for patients with septic shock.

Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J; CORTICUS Study Group.

N Engl J Med. 2008 Jan 10;358(2):111-24. doi: 10.1056/NEJMoa071366.

12.

The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.

Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, Brett SJ.

Crit Care Med. 2014 Jun;42(6):1325-33. doi: 10.1097/CCM.0000000000000212.

PMID:
24557425
13.

Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ; VANISH Investigators.

JAMA. 2016 Aug 2;316(5):509-18. doi: 10.1001/jama.2016.10485.

PMID:
27483065
14.

Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C, Nierhaus A, Jaschinski U, Meier-Hellmann A, Weyland A, Gründling M, Moerer O, Riessen R, Seibel A, Ragaller M, Büchler MW, John S, Bach F, Spies C, Reill L, Fritz H, Kiehntopf M, Kuhnt E, Bogatsch H, Engel C, Loeffler M, Kollef MH, Reinhart K, Welte T; German Study Group Competence Network Sepsis (SepNet).

JAMA. 2012 Jun 13;307(22):2390-9. doi: 10.1001/jama.2012.5833.

PMID:
22692171
15.

Clinical effects of adding fludrocortisone to a hydrocortisone-based shock protocol in hypotensive critically ill children.

Hebbar KB, Stockwell JA, Fortenberry JD.

Intensive Care Med. 2011 Mar;37(3):518-24. doi: 10.1007/s00134-010-2090-3. Epub 2010 Dec 9.

PMID:
21152900
16.

The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.

Galiatsatos P, Gibson BR, Rabiee A, Carlson O, Egan JM, Shannon RP, Andersen DK, Elahi D.

Crit Care Med. 2014 Mar;42(3):638-45. doi: 10.1097/CCM.0000000000000035.

PMID:
24247476
17.

[Glycemic control in sepsis and septic shock: friend or foe?].

Ellger B, Westphal M, Stubbe HD, Van den Heuvel I, Van Aken H, Van den Berghe G.

Anaesthesist. 2008 Jan;57(1):43-8. Review. German.

PMID:
18034219
18.

Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial.

Asehnoune K, Seguin P, Allary J, Feuillet F, Lasocki S, Cook F, Floch H, Chabanne R, Geeraerts T, Roger C, Perrigault PF, Hanouz JL, Lukaszewicz AC, Biais M, Boucheix P, Dahyot-Fizelier C, Capdevila X, Mahe PJ, Le Maguet P, Paugam-Burtz C, Gergaud S, Plaud B, Constantin JM, Malledant Y, Flet L, Sebille V, Roquilly A; Corti-TC Study Group.

Lancet Respir Med. 2014 Sep;2(9):706-16. doi: 10.1016/S2213-2600(14)70144-4. Epub 2014 Jul 24. Erratum in: Lancet Respir Med. 2014 Sep;2(9):e15.

19.

Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality.

Torgersen C, Luckner G, Schröder DC, Schmittinger CA, Rex C, Ulmer H, Dünser MW.

Intensive Care Med. 2011 Sep;37(9):1432-7. doi: 10.1007/s00134-011-2312-3. Epub 2011 Jul 21.

PMID:
21779849
20.

Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial.

Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM.

Ann Intern Med. 2007 Feb 20;146(4):233-43.

PMID:
17310047

Supplemental Content

Support Center